Status:
UNKNOWN
Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease
Lead Sponsor:
Jinling Hospital, China
Collaborating Sponsors:
University Hospital of Limerick
The Cleveland Clinic
Conditions:
Postoperative Surgical Recurrence
Eligibility:
All Genders
16-65 years
Phase:
NA
Brief Summary
The study evaluates whether there is a reduction in the rate of postoperative progression of the disease following extensive mesenteric excision (EME), when compared to that of limited mesenteric exci...
Detailed Description
EME and LME are the two surgical procedures which are commonly used in the treatment of Crohn's disease. However, the areas of the mesenteric tissue resected are different. EME means that the mesente...
Eligibility Criteria
Inclusion
- Patients with Crohn's disease limited to the distal ileum and/or right colon receiving their index ileocolonic resection
- Patients with a documented history of Crohn's disease based on endoscopic, radiological, or histological criteria
Exclusion
- Pregnancy or willingness to become pregnant in the following year
- Previous ileocolic resection history
- Patients having Crohn's disease lesion at a gastrointestinal site other than the terminal ileum cecum, or right colon
- Patients having an internal fistula which required resection of another segment of bowel
Key Trial Info
Start Date :
February 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT03769922
Start Date
February 18 2019
End Date
January 1 2025
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Eastern Theater Command
Nanjing, Jiangsu, China, 210000